Pancreatic Cancer Research

Grant

Interrogating vulnerabilities of a KRAS inhibitor-resistant cell state in pancreatic cancer

Fiscal years
2025–2025
Amount counted
$330,000

These are registry fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try